BrightFocus Foundation

🧠 🧩 Meet Dr. Marta Casquero Veiga. In elementary school, she became enamored with the challenge of understanding the physical world's unsolved puzzles. Now she aims to piece together the biggest puzzle of all—the brain. With funding from BrightFocus Foundation’s Alzheimer’s Disease Research program, she’s developing cutting-edge technology to detect tiny blood clots in the brain, potentially slowing Alzheimer’s progression. Read about her research: bit.ly/AlzPuzzle 📸: Dr. Casquero-Veiga, Alzheimer's Disease Research grant recipient.

Don’t let glaucoma sneak up on your family. Does this describe you or your loved ones? 🔸 Family history of glaucoma 🔸 Older age (60+) 🔸 Hispanic or African heritage 🔸 Myopia/Near-sightedness 🔸 Past eye trauma 🔸 History of using steroid-containing medications If so, it’s time to start a conversation to protect their sight. Check out our discussion guide 👁️🗨️: https://lnkd.in/eHbDs_3c #Health #Family #Glaucoma

Bio-Hermes-002 is an innovative study investigating how blood and digital biomarkers can predict the likelihood of Alzheimer’s pathology. If you’re between 60-90 years old and have a study partner, join our next Zoom In on Dementia & Alzheimer’s episode featuring John Dwyer President of the Global Alzheimer's Platform Foundation to learn how you can get involved. Register to ask your questions live: BrightFocus.org/ZoomIn #Alzheimers #Health #Impact

Please join me and Global Alzheimer's Platform Foundation's John Dwyer to learn about BIO-HERMES-002, an innovative study investigating how blood and digital biomarkers can predict the likelihood of Alzheimer’s pathology. Register today: BrightFocus.org/ADZoom BrightFocus Foundation Sponsored by Biogen, Genentech, Eli Lilly and Company Melody Libby Jenee Williams, MBA Trisha Devlin Julie Sipchen Leigh Zisko Tamiko MaGee-Rodgers, PhD Sean Stanton Debra Tann, Ed.D. George Vradenburg

Thanksgiving is the busiest day for travel in the United States. Are you gearing up for your holiday journey? Dr. Preeti Subramanian, Director, Vision Science Research at BrightFocus Foundation shares must-know travel tips and essential apps for a successful trip with low vision. #Health #Travel #VisionLoss

Check out our perspective on the inclusion of oligodendrocytes in #ADRD research. Diane Bovenkamp As researchers, we’re well aware of the structural and molecular shifts that define Alzheimer’s and related dementias. But amid the focus on neurons, microglia, and astrocytes, we risk overlooking a critical player: oligodendrocytes. Mounting evidence, including recent findings from the Allen Institute, shows that oligodendrocytes experience massive early loss and transcriptomic changes well before neuronal decline becomes apparent. This could be the very first stage in neurodegeneration. The science is there—changes in myelin integrity, regional disconnection, and disease associated oligodendrocyte transcriptomic signatures are repeatedly reported in the literature. If we fail to include these cells as central players in ADRD research, we risk missing crucial insights that could drive new therapeutic approaches. We cannot afford another setback. As we work diligently to continue to disentangle the multifactorial nature of ADRD, we need to continue to broaden our lens. We urge the research community to recognize the foundational role of oligodendrocytes in ADRD onset and progression. Let’s push the field forward by giving these cells the attention they deserve in our studies and funding priorities. BrightFocus Foundation https://lnkd.in/eEmz73rx

❓ You have likely heard about Alzheimer’s blood tests. But do you understand how they work and how to get one? Join us today, Nov 21 at 1 p.m. ET for an in-depth discussion about #Alzheimers blood tests with guest expert Suzanne E. Schindler, MD, PhD, of WashU Medicine. Watch live on YouTube. ⤵️

Did you know that blue light—a high-energy visible light emitted from digital devices and the sun—can damage your eyes and increase risk of macular degeneration? Explore how BrightFocus Macular Degeneration Research grant recipient Dr. Yong-Su Kwon of the University of North Carolina at Chapel Hill is investigating antioxidants as a potential treatment. #MacularDegeneration #Health #Research

Vision loss caused by macular degeneration deeply affects lives by limiting daily activities and independence, and by influencing emotional health. Join our upcoming Macular Chat featuring guest expert Dr. Allysin E. Bridges-German of Towson University to explore adaptive technology, key resources, and practical insights for living well with low vision 🔊 Visit BrightFocus.org/Live-Chat to listen live at 1 p.m. ET today! #VisionLoss #MacularDegeneration #Technology

Researchers are exploring if Kisunla, an anti-amyloid Alzheimer’s therapy, can prevent cognitive decline in people with Alzheimer’s disease before their symptoms begin. Read more about this and learn about other exciting #Alzheimers news announced at #CTAD24: https://lnkd.in/eJGNXRQQ. #ResearchNews #Neuroscience #Health